Gérard Soula
Founder at ADOCIA
Net worth: 9 M $ as of 2024-04-29
Profile
Gérard Soula is the founder.
He founded Flamel Technologies SA in 1990, where he held the title of Chairman & Chief Executive Officer from 1990 to 2005.
He also founded Adocia SA in 2005 and currently serves as Chairman.
Dr. Soula's current job is as a Director at Glowbl SAS.
His former positions include being a Director at Veloxis Pharmaceuticals A and Life Cycle Pharma A.
Dr. Soula obtained a doctorate degree from Université d'Aix-Marseille.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADOCIA SA
6.99% | 2022-12-30 | 1,006,455 ( 6.99% ) | 9 M $ | 2024-04-29 |
Gérard Soula active positions
| Companies | Position | Start |
|---|---|---|
| ADOCIA | Founder | 2005-12-15 |
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Director/Board Member | - |
Former positions of Gérard Soula
| Companies | Position | End |
|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Founder | 2004-12-31 |
| Life Cycle Pharma A/S | Director/Board Member | - |
| VELOXIS PHARMACEUTICALS A/S | Director/Board Member | - |
Training of Gérard Soula
| Université d'Aix-Marseille | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADOCIA | Health Technology |
| Private companies | 4 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Technology Services |
| Life Cycle Pharma A/S |
- Stock Market
- Insiders
- Gérard Soula
